trending Market Intelligence /marketintelligence/en/news-insights/trending/7NqbPHTik1myoZEoRPy_xg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Neuralstem appoints executive chairman; interim CEO to step down

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Neuralstem appoints executive chairman; interim CEO to step down

Neuralstem Inc. named Kenneth Carter executive chairman, effective Jan. 1, 2019.

Carter will replace Jim Scully, who is stepping down as interim CEO.

Carter is chairman of Noble Life Sciences Inc., a pre-clinical contract research organization for biotechnology and pharmaceutical companies.

Neuralstem focuses on researching and developing nervous system therapies.